NORCROSS, Ga.--(BUSINESS WIRE)--Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company driving high-growth revenues through acquisition of valuable brand portfolios and innovative drug development programs, has executed a term sheet for an agreement authorizing River’s Edge Pharmaceuticals, LLC to be the exclusive generic drug distributor of the Company’s Extendryl® and Levall® prescription product lines.
